QSAR studies on 1-phenylbenzimidazoles as inhibitors of the platelet-derived growth factor

Bioorg Med Chem. 2005 Dec 15;13(24):6598-608. doi: 10.1016/j.bmc.2005.06.067. Epub 2005 Oct 17.

Abstract

This work is devoted to the development of quantitative structure-activity relationship (QSAR) models of the biological activity of 123 1-phenylbenzimidazoles as inhibitors of the PDGF receptor. The molecular features are represented by chemical descriptors that have been calculated on geometrical, topological, quantum mechanical, and electronic basis by using CODESSA PRO. The obtained models, linear (multilinear regression) and nonlinear (artificial neural network), are aimed to link the structures to their reported activity log 1/IC50. The former model can be used for physico-chemical interpretation, while the latter possesses a superior predictive ability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzimidazoles / chemical synthesis
  • Benzimidazoles / chemistry*
  • Benzimidazoles / pharmacology*
  • Inhibitory Concentration 50
  • Molecular Structure
  • Platelet-Derived Growth Factor / antagonists & inhibitors*
  • Platelet-Derived Growth Factor / metabolism
  • Quantitative Structure-Activity Relationship

Substances

  • Benzimidazoles
  • Platelet-Derived Growth Factor